Price $4.00 |
Market Cap
191M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
6.11
|
P/S
6.86
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-5.4K
|
FCF
-0.1
|
|
Op. Margin
-39.00%
|
Net Margin
-31.00%
|
ROE
-26.40%
|
ROI
-27.20%
|
|
ROA
-20.30%
|
EPS Growth
-86.50%
|
Current Ratio
4.3
|
Debt/Equity
1.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| XBiotech Inc (XBIT) | $5.11 | - | - | 102.6M | Strong Buy |
| LifeVantage Corp (LFVN) | $4.72 | - | 3.30% | 44.6M | Strong Buy |
| Lifecore Biomedical Inc (LFCR) | $8.15 | - | - | 114.9M | Strong Buy |
| Kamada Ltd. (KMDA) | $4.78 | - | - | 207.1M | Strong Buy |
| Jounce Therapeutics Inc (JNCE) | $1.88 | - | - | 96.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
